Sewoon Medical Co. Ltd (100700) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sewoon Medical Co. Ltd (100700) has a cash flow conversion efficiency ratio of 0.019x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.99 Billion ≈ $2.03 Million USD) by net assets (₩156.24 Billion ≈ $105.88 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 100700 net asset quality score to measure how much of total assets are equity-financed.
Sewoon Medical Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Sewoon Medical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Sewoon Medical Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Sewoon Medical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sewoon Medical Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dutaland Bhd
KLSE:3948
|
-0.019x |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
0.004x |
|
Thorney Opportunities Ltd
AU:TOP
|
0.039x |
|
Loulis Mills S.A.
AT:KYLO
|
0.049x |
|
C3 Metals Inc
V:CCCM
|
-0.012x |
|
Infragreen Group Ltd
AU:IFN
|
-0.004x |
|
XBiotech Inc
NASDAQ:XBIT
|
-0.164x |
|
Yong Pyong Resort Corp
KO:070960
|
0.006x |
Annual Cash Flow Conversion Efficiency for Sewoon Medical Co. Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Sewoon Medical Co. Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 100700 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩154.40 Billion ≈ $104.64 Million |
₩17.77 Billion ≈ $12.04 Million |
0.115x | +27.56% |
| 2024-12-31 | ₩146.12 Billion ≈ $99.02 Million |
₩13.19 Billion ≈ $8.94 Million |
0.090x | -46.16% |
| 2023-12-31 | ₩137.69 Billion ≈ $93.31 Million |
₩23.08 Billion ≈ $15.64 Million |
0.168x | +122.18% |
| 2022-12-31 | ₩123.01 Billion ≈ $83.36 Million |
₩9.28 Billion ≈ $6.29 Million |
0.075x | -59.90% |
| 2021-12-31 | ₩114.13 Billion ≈ $77.35 Million |
₩21.47 Billion ≈ $14.55 Million |
0.188x | -0.36% |
| 2020-12-31 | ₩101.98 Billion ≈ $69.11 Million |
₩19.25 Billion ≈ $13.05 Million |
0.189x | +33.34% |
| 2019-12-31 | ₩95.22 Billion ≈ $64.53 Million |
₩13.48 Billion ≈ $9.14 Million |
0.142x | +0.25% |
| 2018-12-31 | ₩86.35 Billion ≈ $58.52 Million |
₩12.19 Billion ≈ $8.26 Million |
0.141x | +33.38% |
| 2017-12-31 | ₩77.72 Billion ≈ $52.67 Million |
₩8.23 Billion ≈ $5.58 Million |
0.106x | +21.89% |
| 2016-12-31 | ₩73.09 Billion ≈ $49.53 Million |
₩6.35 Billion ≈ $4.30 Million |
0.087x | +56.05% |
| 2015-12-31 | ₩65.61 Billion ≈ $44.47 Million |
₩3.65 Billion ≈ $2.48 Million |
0.056x | -57.37% |
| 2014-12-31 | ₩64.35 Billion ≈ $43.61 Million |
₩8.40 Billion ≈ $5.69 Million |
0.131x | -20.28% |
| 2013-12-31 | ₩58.72 Billion ≈ $39.80 Million |
₩9.62 Billion ≈ $6.52 Million |
0.164x | +16.78% |
| 2012-12-31 | ₩51.25 Billion ≈ $34.73 Million |
₩7.19 Billion ≈ $4.87 Million |
0.140x | +26.92% |
| 2011-12-31 | ₩46.71 Billion ≈ $31.65 Million |
₩5.16 Billion ≈ $3.50 Million |
0.111x | -- |
About Sewoon Medical Co. Ltd
Sewoon Medical Co., Ltd. engages in the research and development, manufacture, and sale of medical products. Its products include wound drainage systems, urinary catheters and tubes, drainage catheters and tubes, respiratory and tracheal tubes, infusion catheters and tubes, and wound care products. The company also offers unigel, thermosens, epistim, bonastent, and other products. Sewoon Medical … Read more